Literature DB >> 7511781

N-methyl-D-aspartate receptors: different subunit requirements for binding of glutamate antagonists, glycine antagonists, and channel-blocking agents.

D R Lynch1, N J Anegawa, T Verdoorn, D B Pritchett.   

Abstract

Expression of the NR-1 subunit in Xenopus oocytes produces channels that respond to glutamate and are blocked by competitive and noncompetitive antagonists of the N-methyl-D-aspartate (NMDA) receptor. Ionic conductances through these channels are increased by coexpression with NR-2 receptor subunits. We have characterized the pharmacological properties of NMDA receptors assembled from combinations of subunits expressed in transfected cells, to determine the minimum subunit requirements for binding of competitive glutamate antagonists, glycine antagonists, and channel-blocking agents, as detected by ligand-binding experiments. Expression of NR-1a alone produced glycine antagonist binding, whereas the combination of NR-1a and NR-2A was needed to produce binding sites for glutamate antagonists and channel-blocking agents. These results suggest that functional NMDA receptors assemble from these subunits. However, differences in the pharmacological effects of NMDA and polyamines show that not all characteristics of native NMDA receptors are reproduced by this combination of subunits.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7511781

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  30 in total

1.  Selective activation induced cleavage of the NR2B subunit by calpain.

Authors:  Kelly L Simpkins; Rodney P Guttmann; Yina Dong; Zhaoming Chen; Set Sokol; Robert W Neumar; David R Lynch
Journal:  J Neurosci       Date:  2003-12-10       Impact factor: 6.167

2.  Glycine transporter 1 modulates GABA release from amacrine cells by controlling occupancy of coagonist binding site of NMDA receptors.

Authors:  Eva Rozsa; Jozsef Vigh
Journal:  J Neurophysiol       Date:  2013-06-26       Impact factor: 2.714

3.  Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain. A quantitative in situ hybridization study.

Authors:  P A Boyer; P Skolnick; L H Fossom
Journal:  J Mol Neurosci       Date:  1998-06       Impact factor: 3.444

4.  D-serine as a neuromodulator: regional and developmental localizations in rat brain glia resemble NMDA receptors.

Authors:  M J Schell; R O Brady; M E Molliver; S H Snyder
Journal:  J Neurosci       Date:  1997-03-01       Impact factor: 6.167

5.  Allosteric modulation of [3H]-CGP39653 binding through the glycine site of the NMDA receptor: further studies in rat and human brain.

Authors:  M Mugnaini; P Meoni; B Bunnemann; M Corsi; N G Bowery
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

6.  Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain.

Authors:  M Mugnaini; F T van Amsterdam; E Ratti; D G Trist; N G Bowery
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

7.  A novel substituted aminoquinoline selectively targets voltage-sensitive sodium channel isoforms and NMDA receptor subtypes and alleviates chronic inflammatory and neuropathic pain.

Authors:  Boris Tabakoff; Wenhua Ren; Lauren Vanderlinden; Lawrence D Snell; Christopher J Matheson; Ze-Jun Wang; Rock Levinson; C Thetford Smothers; John J Woodward; Yumiko Honse; David Lovinger; Anthony M Rush; William A Sather; Daniel L Gustafson; Paula L Hoffman
Journal:  Eur J Pharmacol       Date:  2016-05-05       Impact factor: 4.432

8.  Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane.

Authors:  A W Dunah; D G Standaert
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

9.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

Authors:  Josep Dalmau; Amy J Gleichman; Ethan G Hughes; Jeffrey E Rossi; Xiaoyu Peng; Meizan Lai; Scott K Dessain; Myrna R Rosenfeld; Rita Balice-Gordon; David R Lynch
Journal:  Lancet Neurol       Date:  2008-10-11       Impact factor: 44.182

10.  N-methyl-D-aspartate 2b receptor subtype (NR2B) promoter methylation in patients during alcohol withdrawal.

Authors:  Teresa Biermann; Udo Reulbach; Bernd Lenz; Helge Frieling; Marc Muschler; Thomas Hillemacher; Johannes Kornhuber; Stefan Bleich
Journal:  J Neural Transm (Vienna)       Date:  2009-04-07       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.